Medicaid Rebate Net Price
Definition
The Medicaid rebate net price is the price state Medicaid programs effectively pay for covered outpatient drugs after manufacturer rebates are applied. While states initially pay the pharmacy reimbursement rate (such as AAC or EAC plus a dispensing fee), they subsequently collect rebates from manufacturers under the Medicaid Drug Rebate Program (MDRP). The net price after rebates is typically significantly lower than the initial payment.
In the 340B context, the Medicaid rebate net price is relevant to the duplicate discount prohibition. The purpose of the prohibition is to prevent both the 340B discount and the Medicaid rebate from applying to the same drug transaction—which would result in the manufacturer providing two separate discounts on the same unit. The MEF and Medicaid carve-out/carve-in designations are designed to prevent this from occurring.
Frequently Asked Questions
Why Medicaid Rebate Net Price Matters
Understanding the Medicaid rebate net price helps covered entities understand why the duplicate discount prohibition exists and why proper Medicaid billing designations are essential to program integrity.
How Virtue 340B Uses It
Virtue 340B references the Medicaid rebate net price concept when explaining duplicate discount prevention to covered entity clients.